OVARIAN NEOPLASMS
Clinical trials for OVARIAN NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new OVARIAN NEOPLASMS trials appear
Sign up with your email to follow new studies for OVARIAN NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer pill tested in 23 patients, study halted early
Disease control TerminatedThis early-stage study tested an experimental oral drug called NKT3447 in 23 adults with advanced solid tumors that had stopped responding to standard treatments. The goal was to check safety and find the right dose. The study was terminated early, so results are limited.
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 04:51 UTC
-
Ovarian cancer drug trial halted early: niraparib vs chemo
Disease control TerminatedThis study aimed to see if the drug niraparib works better than standard chemotherapy for people with advanced ovarian cancer that has a specific genetic feature (HRd). The trial was stopped early after enrolling 36 participants. Researchers planned to measure tumor shrinkage bef…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE2 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called felmetatug vedotin, alone or with pembrolizumab, in people with advanced solid tumors (like ovarian, breast, lung, and others). The goal was to check safety and find the right dose. The trial was terminated early, so results are limited.
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 18, 2026 11:59 UTC